Completed NA INTERVENTIONAL 1-arm NCT01479218

Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus

Sponsor: Occlutech International AB

Updated 7 times since 2017 Last updated: Feb 13, 2024 Started: Nov 30, 2011 Primary completion: Feb 28, 2014 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01479218, this NA trial focuses on Patent Ductus Arteriosus and remains completed. Sponsored by Occlutech International AB, it has been updated 7 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2024 — Jul 2024 [monthly]

Completed NA

Phase: PHASE1 → NA
Jan 2021 — Mar 2024 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Occlutech International AB

Data source: Occlutech International AB

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hochiminh City, Vietnam
• Kuala Lumpur, Malaysia